BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 8412625)

  • 1. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Yersinia enterocolitica and the host with special reference to virulence plasmid encoded adhesion and humoral immunity.
    Paerregaard A
    Dan Med Bull; 1992 Apr; 39(2):155-72. PubMed ID: 1611921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
    Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens.
    Simonet M; Berche P; Mazigh D; Veron M
    J Med Microbiol; 1985 Oct; 20(2):225-31. PubMed ID: 3900406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the virulence gene products of Yersinia enterocolitica in the immune response of infected mice.
    Takeuchi O; Suzuki T; Kawamura I; Kobayashi N; Takizawa-Hashimoto A; Mitsuyama M
    FEMS Immunol Med Microbiol; 2005 Aug; 45(2):321-9. PubMed ID: 16019194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity induced by a Yersinia enterocolitica serovar 0:8 cellular extract.
    Di Genaro MS; Escudero ME; Maccioni M; Stefanini de Guzmán AM
    Biocell; 1996 Dec; 20(3):235-41. PubMed ID: 9031590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral infection by Y. enterocolitica 0:8. Studies of immunization in a murine model].
    Frades MC; Díaz R
    Enferm Infecc Microbiol Clin; 1991 Dec; 9(10):608-12. PubMed ID: 1822150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells.
    Bohn E; Autenrieth IB
    J Immunol; 1996 Feb; 156(4):1458-68. PubMed ID: 8568248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of V antigen in promoting virulence and immunity in yersiniae.
    Une T; Brubaker RR
    J Immunol; 1984 Oct; 133(4):2226-30. PubMed ID: 6381597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of chromosomal and plasmid--encoded virulence determinants in Yersinia enterocolitica and other Yersinia spp. isolated from food animals in Greece.
    Kechagia N; Nicolaou C; Ioannidou V; Kourti E; Ioannidis A; Legakis NJ; Chatzipanagiotou S
    Int J Food Microbiol; 2007 Sep; 118(3):326-31. PubMed ID: 17825934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
    Heesemann J; Gaede K; Autenrieth IB
    APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.
    Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM
    Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of B cell response during Yersinia enterocolitica infection in resistant and susceptible strains of mice.
    Cangiani EE; Guiraldi FR; Pinto SE; de Medeiros BM
    Immunol Invest; 2007; 36(4):387-402. PubMed ID: 17691021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated protection against Brucella abortus in BALB/c mice at successive periods after infection: variation between virulent strain 2308 and attenuated vaccine strain 19.
    Elzer PH; Jacobson RH; Jones SM; Nielsen KH; Douglas JT; Winter AJ
    Immunology; 1994 Aug; 82(4):651-8. PubMed ID: 7835931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the usefulness of selected virulence markers for identification of virulent Yersinia enterocolitica strains. II. Genotypic markers associated with the pYV plasmid].
    Gierczyński R
    Med Dosw Mikrobiol; 2000; 52(1):35-49. PubMed ID: 11107778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant bivalent fusion protein rVE confers active and passive protection against Yersinia enterocolitica infection in mice.
    Singh AK; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 Mar; 32(11):1233-9. PubMed ID: 24486353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heat-modifiable outer membrane protein carries an antigen specific for the species Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Ogasawara M; Kobayashi S; Arai S; Laheji K; Hill JL; Kono DH; Yu DT
    J Immunol; 1985 Aug; 135(2):1430-6. PubMed ID: 2409152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host responses to infection with Yersinia enterocolitica.
    Carter PB; MacDonald TT; Collins FM
    Contrib Microbiol Immunol; 1979; 5():346-50. PubMed ID: 535391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells.
    Erfurth SE; Gröbner S; Kramer U; Gunst DS; Soldanova I; Schaller M; Autenrieth IB; Borgmann S
    Infect Immun; 2004 Dec; 72(12):7045-54. PubMed ID: 15557628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.